Managing Port-Site Bleeding during Less Invasive Coronary Artery Bypass Grafting


  • Soroosh Kiani
  • Mary-Lynn Brecht
  • Katherine Lovinger
  • Robert S. Poston



Introduction: Robotic-assisted coronary artery bypass grafting (r-CABG) requires the placement of ports bluntly through the chest wall. When removed, these ports create bleeding sites that can be difficult to detect and treat. This study evaluated whether a topical hemostatic agent placed locally within these sites helps to reduce bleeding and blood product requirements.

Methods: We retrospectively analyzed outcomes for r-CABG cases where 5 mL of a flowable hemostatic agent was injected locally within all port sites (hemostat group, n = 62) compared with patients whose port sites were untreated (controls, n = 131). Outcomes included chest tube output, red blood cell (RBC) transfusions, length of hospital stay, and the risk of reoperation for bleeding. Analyses were adjusted for risk factors known to influence bleeding and Society of Thoracic Surgeons (STS) risk score as a weighted composite of variables, which controls for patient and clinical variables.

Results: The 2 study groups had similar baseline characteristics and underwent the same r-CABG procedure. The hemostat group had significant reductions in RBC transfusion (24.2% versus 40.8% receiving blood; P = .026; 0.44 versus 1.39 U transfused postoperatively, P = .024). After adjustment for bleeding risks (using STS risk score), differences in transfusions remained significant. Reoperation rates for bleeding, length of stay, chest tube drainage, and intraoperative transfusions were not significantly different in the 2 groups.

Conclusions: There was significantly reduced postoperative bleeding and less exposure to blood products in the hemostat group. These findings suggest that undetected bleeding from sites used for port access serves as an underappreciated source of morbidity after r-CABG.


Ahlering TE, Eichel L, Chou D, Skarecky DW. 2005. Feasibility study for robotic radical prostatectomy cautery-free neurovascular bundle preservation. Urology 65:994-7.nBonatti J, Schachner T, Bonaros N, et al. 2009. Effectiveness and safety of total endoscopic left internal mammary artery bypass graft to the left anterior descending artery. Am J Cardiol 104:1684-8.nCôté D, Barber B, Diamond C, Wright E. 2010. FloSeal hemostatic matrix in persistent epistaxis: prospective clinical trial. J Otolaryngol Head Neck Surg 39:304-8.nDesai PH, Tran R, Steinwagner T, Poston RS. 2010. Challenges of telerobotics in coronary bypass surgery. Expert Rev Med Devices 7:165-8.nFerguson TB Jr, Hammill BG, Peterson ED, DeLong ER, Grover FL; STS National Database Committee. 2002. A decade of change—risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990-1999: a report from the STS National Database Committee and the Duke Clinical Research Institute. Society of Thoracic Surgeons. Ann Thorac Surg 73:480-9.nHo H, Schwentner C, Neururer R, Steiner H, Bartsch G, Peschel R. 2009. Robotic-assisted laparoscopic partial nephrectomy: surgical technique and clinical outcomes at 1 year. BJU Int 103:663-8.nJameson M, Gross CW, Kountakis SE. 2006. FloSeal use in endoscopic sinus surgery: effect on postoperative bleeding and synechiae formation. Am J Otolaryngol 27:86-90.nKaul S, Laungani R, Sarle R, et al. 2007. da Vinci-assisted robotic partial nephrectomy: technique and results at a mean of 15 months of follow-up. Eur Urol 51:186-91.nKoch CG, Khandwala F, Li L, Estafanous FG, Loop FD, Blackstone EH. 2006a. Persistent effect of red cell transfusion on health-related quality of life after cardiac surgery. Ann Thorac Surg 82:13-20.nKoch CG, Li L, Duncan AI, et al. 2006b. Transfusion in coronary artery bypass grafting is associated with reduced long-term survival. Ann Thorac Surg 81:1650-7.nLoop FD, Lytle BW, Cosgrove DM, et al. 1986. Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. N Engl J Med 314:1-6.nMalenka DJ, Leavitt BJ, Hearne MJ, et al. 2005. Comparing long-term survival of patients with multivessel coronary disease after CABG or PCI: analysis of BARI-like patients in northern New England. Circulation 112(9 Suppl):I371-6.nMohr FW, Falk V, Diegeler A, Autschback R. 1999. Computer-enhanced coronary artery bypass surgery. J Thorac Cardiovasc Surg 117:1212-4.nMohr FW, Falk V, Diegeler A, et al. 2001. Computer-enhanced "robotic" cardiac surgery: experience in 148 patients. J Thorac Cardiovasc Surg 121:842-53.nMorgan JA, Peacock JC, Kohmoto T, et al. 2004. Robotic techniques improve quality of life in patients undergoing atrial septal defect repair. Ann Thorac Surg 77:1328-33.nMurphy GJ, Reeves BC, Rogers CA, Rizvi SI, Culliford L, Angelini GD. 2007. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation 116:2544-52.nNasso G, Piancone F, Bonifazi R, et al. 2009. Prospective, randomized clinical trial of the FloSeal matrix sealant in cardiac surgery. Ann Thorac Surg 88:1520-6.nOz MC, Cosgrove DM 3rd, Badduke BR, et al. 2000. Controlled clinical trial of a novel hemostatic agent in cardiac surgery. The Fusion Matrix Study Group. Ann Thorac Surg 69:1376-82.nOz MC, Rondinone JF, Shargill NS. 2003. FloSeal Matrix: new generation topical hemostatic sealant. J Card Surg 18:486-93.nPoston RS, Tran R, Collins M, et al. 2008. Comparison of economic and patient outcomes with minimally invasive versus traditional off-pump coronary artery bypass grafting techniques. Ann Surg 248:638-46.nPoston RS, White C, Gu J, et al. 2006. Aprotinin shows both hemostatic and antithrombotic effects during off-pump coronary artery bypass grafting. Ann Thorac Surg 81:104-11.nRenkens KL Jr, Payner TD, Leipzig TJ, et al. 2001. A multicenter, prospective, randomized trial evaluating a new hemostatic agent for spinal surgery. Spine (Phila Pa 1976) 26:1645-50.nRobicsek F. 2008. Robotic cardiac surgery: time told! J Thorac Cardiovasc Surg 135:243-6.nRoger VL, Go AS, Lloyd-Jones DM, et al. 2011. Heart disease and stroke statistics—2011 update: a report from the American Heart Association. Circulation 123:e18-e209.nSedrakyan A, Wu AW, Parashar A, Bass EB, Treasure T. 2006. Off-pump surgery is associated with reduced occurrence of stroke and other morbidity as compared with traditional coronary artery bypass grafting: a meta-analysis of systematically reviewed trials. Stroke 37:2759-69.nvan Straten AH, Bekker MW, Soliman Hamad MA, et al. 2010. Transfusion of red blood cells: the impact on short-term and long-term survival after coronary artery bypass grafting, a ten-year follow-up. Interact Cardiovasc Thorac Surg 10:37-42.n



How to Cite

Kiani, S., Brecht, M.-L., Lovinger, K., & Poston, R. S. (2012). Managing Port-Site Bleeding during Less Invasive Coronary Artery Bypass Grafting. The Heart Surgery Forum, 15(5), E272-E276.




Most read articles by the same author(s)